This article was written with the assistance of A.I. technology, and has been edited and fact-checked by Colman Andrews. Cancer is a disease that has been with us for a long time, and it is still a...
Chronic obstructive pulmonary disease is an umbrella term for progressive lung diseases, primarily chronic bronchitis and emphysema — conditions that make breathing increasingly difficult. Most...
The lunacy of the behavior of Congress and the White House has made the decisions of what investors, companies and local governments, which depend on the nation's Aaa rating, should do all the more...
Lucas Energy announced that is has signed a purchase agreement to acquire, from 21 different entities and individuals, working interests in producing properties and undeveloped acreage.
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is surging on news updating its non-small cell lung cancer trial. The company said that interim results were presented from its 121 patient randomized,...
Adidas AG (ADDYY) reported its most recent quarterly results before the markets opened on Wednesday. Overall, the company delivered solid results which culminated a year of impressive sales. However...
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer.
What does the recent jump mean for the Terra Classic community and does LUNC have a future?
Bronchus Technologies, Inc. filed yesterday for an initial public offering of up to $86.25 million for filing purposes.  It has the proposed ticker of "LUNG" on NASDAQ, and the lead...
Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in...
This Yale lawyer says current antitrust laws are enabling Apple, not reining it in.
Source: ThinkstockOncolytics Biotech Inc. (NASDAQ: ONCY) just reasserted its position on the map again. The company has announced test results showing tumor shrinkage data from its U.S. Phase II...
Savara shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary alveolar proteinosis. Unfortunately, the study did not...
Source: courtesy of NBN at German WikipediaThe news around tobacco and smoking cigarettes has been dominated by the trends around the e-cigarette market in 2013, but perhaps something else is afoot...
Big movers on Wednesday were two companies that reported results late Tuesday. Big movers Thursday morning were different.